Hochschulschrift
Mechanism of liver cell injury by the cytostatic drug melphalan
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Konstanz, Univ., Diss., 2005
- Klassifikation
-
Medizin, Gesundheit
- Schlagwort
-
Apoptosis ; Maus ; Leberperfusion ; Tumor-Nekrose-Faktor
- Urheber
-
Kresse, Matthias
- URN
-
urn:nbn:de:bsz:352-opus-14641
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Kresse, Matthias
Ähnliche Objekte (12)
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
New approaches to improve prediction of drug-induced liver injury
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
T cell-dependent inflammatory liver injury in mice
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
Delection of Caspase-8 in liver parenchymal cells protects against cholestatic liver injury
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
New approaches to improve prediction of drug-induced liver injury
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
T cell-dependent inflammatory liver injury in mice
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
Delection of Caspase-8 in liver parenchymal cells protects against cholestatic liver injury
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
New approaches to improve prediction of drug-induced liver injury
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
T cell-dependent inflammatory liver injury in mice
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
Delection of Caspase-8 in liver parenchymal cells protects against cholestatic liver injury